CYH vs MD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 28, 2026
CYH
42.3
AI Score
VS
MD Wins
MD
61.6
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | CYH | MD | Winner |
|---|---|---|---|
| Net Income | 509.00M | 69.42M | CYH |
| Operating Income | 1.49B | 98.58M | CYH |
| ROE | -36.5% | 7.9% | MD |
| ROA | 3.9% | 3.3% | CYH |
| Total Assets | 13.20B | 2.13B | CYH |
| Cash | 260.00M | 288.88M | MD |
| Debt/Equity | -7.46 | 0.69 | CYH |
| Current Ratio | 1.46 | 1.32 | CYH |
Relative Price Performance (Last 90 Days)
CYH 1M: -6.1%
· 3M: -29.5%
MD 1M: -2.7%
· 3M: -3.7%
Current Technical Phase
CYH
MarkdownSell / avoid
Price below a falling SMA50 (slope -6.5%), weak momentum, RSI 38
MD
NeutralHold
Mixed signals - no dominant trend phase, RSI 45
Fundamentals Snapshot
| Metric | CYH | MD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -5.3 | 10.6 |
| Trailing P/E | 1.5 | 12.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.0% |
| Gross Margin | 0.4% | 0.3% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 1.85 | 2.06 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, MD is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.